Abstract
The HIV-1 Rev protein, which traffics through nucleolus and shuttles between nucleus and cytoplasm, facilitates export of unspliced and singly spliced viral transcripts containing RRE RNA by the CRM1 export pathway. Inhibitions of the various stages of Rev-mediated RNA transport can arrest HIV-1 transcriptional process. The current understanding to the mechanism of Rev function, Rev-RRE interaction, as well as inhibitors hereof is reviewed.
Keywords: AIDS, HIV-1, transcription, inhibitors, Rev, RRE, antiviral
Current HIV Research
Title: Cessation of HIV-1 Transcription by Inhibiting Regulatory Protein Rev- Mediated RNA Transport
Volume: 7 Issue: 1
Author(s): Yuan Cao, Xinyong Liu and Erik De Clercq
Affiliation:
Keywords: AIDS, HIV-1, transcription, inhibitors, Rev, RRE, antiviral
Abstract: The HIV-1 Rev protein, which traffics through nucleolus and shuttles between nucleus and cytoplasm, facilitates export of unspliced and singly spliced viral transcripts containing RRE RNA by the CRM1 export pathway. Inhibitions of the various stages of Rev-mediated RNA transport can arrest HIV-1 transcriptional process. The current understanding to the mechanism of Rev function, Rev-RRE interaction, as well as inhibitors hereof is reviewed.
Export Options
About this article
Cite this article as:
Cao Yuan, Liu Xinyong and De Clercq Erik, Cessation of HIV-1 Transcription by Inhibiting Regulatory Protein Rev- Mediated RNA Transport, Current HIV Research 2009; 7 (1) . https://dx.doi.org/10.2174/157016209787048564
DOI https://dx.doi.org/10.2174/157016209787048564 |
Print ISSN 1570-162X |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4251 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Transient Receptor Potential Channels - Emerging Novel Drug Targets for the Treatment of Pain
Current Medicinal Chemistry Serum Albumin Concentration and Cognitive Impairment
Current Alzheimer Research Status Epilepticus: An Overview
Current Drug Metabolism Will it Ever Become Possible to Prevent Dopaminergic Neuronal Degeneration?
CNS & Neurological Disorders - Drug Targets QSAR, Docking, and CoMFA Studies of GSK3 Inhibitors
Current Pharmaceutical Design Natural Product-Derived Small Molecule Activators of Hypoxia-Inducible Factor-1 (HIF-1)
Current Pharmaceutical Design PPARs in Diseases: Control Mechanisms of Inflammation
Current Medicinal Chemistry Optimizing Contrast Effect in T1-Weighted Magnetic Resonance Imaging of Gd2O3-Based Nano-Agent via Dopamine Chelation
Neuroscience and Biomedical Engineering (Discontinued) No Increase in HIV Drug Resistance Mutations among Injecting Drug Users on Methadone Maintenance Therapy: A Prospective Cohort Study
Current HIV Research Finding Simple Rules for Discriminating Folding Rate Change upon Single Mutation by Statistical and Learning Methods
Protein & Peptide Letters Relapse Prevention
Adolescent Psychiatry G-Protein-Coupled Receptors Oligomerization: Emerging Signaling Units and New Opportunities for Drug Design
Current Protein & Peptide Science Antidotal Effects of Curcumin Against Agents-Induced Cardiovascular Toxicity
Cardiovascular & Hematological Disorders-Drug Targets Assessment of a Synthetic Steroid and Flutamide on Dopamine, GSH and H<sub>2</sub>O<sub>2</sub> Levels in Rat Brain in Presence of Fructose
Endocrine, Metabolic & Immune Disorders - Drug Targets Terpenes and Phenylpropanoids as Acetyl- and Butyrylcholinesterase Inhibitors: A Comparative Study
Current Alzheimer Research Design and Development of Signal Transduction Inhibitors for Cancer Treatment: Experience and Challenges with Kinase Targets
Current Signal Transduction Therapy Drug release from ordered mesoporous silicas
Current Pharmaceutical Design Protease-Activated Receptor 2: Are Common Functions in Glial and Immune Cells Linked to Inflammation-Related CNS Disorders?
Current Drug Targets Inflammatory Process in Alzheimer’s and Parkinson's Diseases: Central Role of Cytokines
Current Pharmaceutical Design Inhibitors of Nitrogen Oxide Species Production in Animal Models of Inflammation and Future Directions for Therapy in Inflammatory Disorders
Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents